Limited Utility of Pulmonary Nodule Risk Calculators for Managing Large Nodules

Curr Probl Diagn Radiol. 2018 Jan-Feb;47(1):23-27. doi: 10.1067/j.cpradiol.2017.04.003. Epub 2017 Apr 8.

Abstract

Rationale and objectives: The optimal management of large pulmonary nodules, at higher risk for lung cancer, has not been determined, and it remains unclear as to which patients should undergo follow-up imaging vs invasive tissue diagnosis via biopsy or surgical resection.

Materials and methods: Through search of radiology reports, 86 nodules from our institution were identified using the inclusion criterion of solid nodules measuring greater than 8mm. We evaluated these nodules with a number of risk prediction calculators, including the Brock University model, and compared these against the proven diagnosis.

Results: Of 86 nodules, 59 (69%) nodules were malignant. The most accurate predictive model, the Brock University calculator, underestimated the risk for this group at 33%. At its optimal threshold, this model had a positive predictive value of 81% and negative predictive value of 53%. Notwithstanding the low negative predictive value, the positive predictive value was no better than patients clinically selected for biopsy (86% of biopsies were malignant).

Conclusion: Existing nodule risk prediction calculators are of limited usage in guiding the management of large pulmonary nodules. At present, the accuracy of these models in this setting is inferior to expert clinical judgment, and future work is needed to develop management algorithms for higher-risk nodules.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Biopsy
  • Female
  • Humans
  • Lung Neoplasms / diagnostic imaging*
  • Lung Neoplasms / pathology
  • Lung Neoplasms / therapy
  • Male
  • Middle Aged
  • Patient Selection*
  • Predictive Value of Tests
  • Risk Assessment / methods*
  • Risk Factors
  • Solitary Pulmonary Nodule / diagnostic imaging*
  • Solitary Pulmonary Nodule / pathology
  • Solitary Pulmonary Nodule / therapy
  • Tomography, X-Ray Computed*
  • Tumor Burden